CPHI
Price
$1.49
Change
-$0.05 (-3.25%)
Updated
Aug 8, 04:59 PM (EDT)
Capitalization
4.84M
TAK
Price
$14.45
Change
+$0.08 (+0.56%)
Updated
Aug 8, 04:59 PM (EDT)
Capitalization
45.75B
83 days until earnings call
Interact to see
Advertisement

CPHI vs TAK

Header iconCPHI vs TAK Comparison
Open Charts CPHI vs TAKBanner chart's image
China Pharma Holdings
Price$1.49
Change-$0.05 (-3.25%)
Volume$144
Capitalization4.84M
Takeda Pharmaceutical
Price$14.45
Change+$0.08 (+0.56%)
Volume$23.51K
Capitalization45.75B
CPHI vs TAK Comparison Chart in %
Loading...
CPHI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CPHI vs. TAK commentary
Aug 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPHI is a Hold and TAK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 09, 2025
Stock price -- (CPHI: $1.54 vs. TAK: $14.36)
Brand notoriety: CPHI and TAK are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CPHI: 12% vs. TAK: 115%
Market capitalization -- CPHI: $18.31M vs. TAK: $43.11B
CPHI [@Pharmaceuticals: Other] is valued at $18.31M. TAK’s [@Pharmaceuticals: Other] market capitalization is $43.11B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CPHI’s FA Score shows that 0 FA rating(s) are green whileTAK’s FA Score has 2 green FA rating(s).

  • CPHI’s FA Score: 0 green, 5 red.
  • TAK’s FA Score: 2 green, 3 red.
According to our system of comparison, TAK is a better buy in the long-term than CPHI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CPHI’s TA Score shows that 3 TA indicator(s) are bullish while TAK’s TA Score has 5 bullish TA indicator(s).

  • CPHI’s TA Score: 3 bullish, 4 bearish.
  • TAK’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, TAK is a better buy in the short-term than CPHI.

Price Growth

CPHI (@Pharmaceuticals: Other) experienced а -9.65% price change this week, while TAK (@Pharmaceuticals: Other) price change was +4.66% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.81%. For the same industry, the average monthly price growth was +5.43%, and the average quarterly price growth was +86.62%.

Reported Earning Dates

TAK is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.81% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TAK($45.8B) has a higher market cap than CPHI($4.84M). TAK YTD gains are higher at: 8.459 vs. CPHI (-33.548). TAK has higher annual earnings (EBITDA): 1.13T vs. CPHI (-2.21M). TAK has more cash in the bank: 419B vs. CPHI (413K). CPHI has less debt than TAK: CPHI (3.51M) vs TAK (4.51T). TAK has higher revenues than CPHI: TAK (4.48T) vs CPHI (4.3M).
CPHITAKCPHI / TAK
Capitalization4.84M45.8B0%
EBITDA-2.21M1.13T-0%
Gain YTD-33.5488.459-397%
P/E RatioN/A49.71-
Revenue4.3M4.48T0%
Total Cash413K419B0%
Total Debt3.51M4.51T0%
FUNDAMENTALS RATINGS
CPHI vs TAK: Fundamental Ratings
CPHI
TAK
OUTLOOK RATING
1..100
5113
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
7
Undervalued
PROFIT vs RISK RATING
1..100
10098
SMR RATING
1..100
9888
PRICE GROWTH RATING
1..100
8458
P/E GROWTH RATING
1..100
10032
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TAK's Valuation (7) in the Pharmaceuticals Major industry is somewhat better than the same rating for CPHI (45) in the Pharmaceuticals Generic industry. This means that TAK’s stock grew somewhat faster than CPHI’s over the last 12 months.

TAK's Profit vs Risk Rating (98) in the Pharmaceuticals Major industry is in the same range as CPHI (100) in the Pharmaceuticals Generic industry. This means that TAK’s stock grew similarly to CPHI’s over the last 12 months.

TAK's SMR Rating (88) in the Pharmaceuticals Major industry is in the same range as CPHI (98) in the Pharmaceuticals Generic industry. This means that TAK’s stock grew similarly to CPHI’s over the last 12 months.

TAK's Price Growth Rating (58) in the Pharmaceuticals Major industry is in the same range as CPHI (84) in the Pharmaceuticals Generic industry. This means that TAK’s stock grew similarly to CPHI’s over the last 12 months.

TAK's P/E Growth Rating (32) in the Pharmaceuticals Major industry is significantly better than the same rating for CPHI (100) in the Pharmaceuticals Generic industry. This means that TAK’s stock grew significantly faster than CPHI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CPHITAK
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
39%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
42%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
47%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
40%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
40%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
42%
Advances
ODDS (%)
Bullish Trend 15 days ago
82%
Bullish Trend 2 days ago
42%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 15 days ago
45%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
40%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
42%
View a ticker or compare two or three
Interact to see
Advertisement
CPHI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TAK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MUSQ28.250.15
+0.55%
MUSQ Global Music Industry Idx ETF
TBLU54.090.26
+0.48%
Tortoise Global Water Fund
ETO27.120.05
+0.18%
Eaton Vance Tax-Advantaged Global Div Oppor Fund
TECL103.370.12
+0.12%
Direxion Daily Technology Bull 3X ETF
SMIZ34.65-0.21
-0.60%
Zacks Small/Mid Cap ETF

CPHI and

Correlation & Price change

A.I.dvisor tells us that CPHI and ASRT have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CPHI and ASRT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPHI
1D Price
Change %
CPHI100%
-1.59%
ASRT - CPHI
26%
Poorly correlated
-1.60%
TAK - CPHI
26%
Poorly correlated
+0.63%
HCM - CPHI
24%
Poorly correlated
-9.01%
CRON - CPHI
23%
Poorly correlated
+8.10%
PAHC - CPHI
22%
Poorly correlated
+3.17%
More

TAK and

Correlation & Price change

A.I.dvisor indicates that over the last year, TAK has been loosely correlated with HLN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TAK jumps, then HLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TAK
1D Price
Change %
TAK100%
+0.63%
HLN - TAK
41%
Loosely correlated
+2.27%
SGIOY - TAK
41%
Loosely correlated
-0.21%
ESAIY - TAK
35%
Loosely correlated
+2.37%
BNXTF - TAK
32%
Poorly correlated
+22.40%
TKPHF - TAK
27%
Poorly correlated
+3.86%
More